Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZKY001 for Neurotrophic Keratitis
NCT07120308Phase 2Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Sep 2021
- Primary completion
- Jan 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of germinal peptide in neurotrophic keratitis (NK), sponsored by Zhaoke Ophthalmology. Started Sep 2021; status: completed.
02
Drugs
germinal peptide
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on NCT07120308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07120308.